胶质瘤化疗现状与展望
发布时间:2018-04-27 15:35
本文选题:胶质瘤细胞 + 恶性胶质瘤 ; 参考:《广东医学》2017年01期
【摘要】:正神经胶质瘤是中枢神经系统最常见原发性肿瘤,占颅内肿瘤的40%以上。在15岁以下儿童和15~34岁成年人群的癌症死亡患者中,脑胶质瘤是第二大原因。脑胶质瘤,特别是高级别胶质瘤(WHO分类Ⅲ~Ⅳ级肿瘤,也称恶性胶质瘤)发病多在青壮年,治疗困难,预后差。目前,恶性胶质瘤
[Abstract]:Positive glioma is the most common primary tumor in the central nervous system, accounting for more than 40% of intracranial tumors. Gliomas are the second leading cause of cancer deaths among children under 15 and adults aged 15-34. Brain gliomas, especially high-grade gliomas, are classified by WHO as grade 鈪,
本文编号:1811298
本文链接:https://www.wllwen.com/yixuelunwen/zlx/1811298.html